Eli Lilly Scores Tax Break for Diabetes Drugs in NC
Published Date: 9/25/2026
Notice
Summary
Eli Lilly wants to start making several special drug products at their Durham, North Carolina facility under Foreign-Trade Zone 93. This means they can use certain imported materials without paying duties while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The change could speed up production and save money, with the proposal officially received on September 17, 2026.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Eli Lilly seeks duty‑free FTZ production
Eli Lilly filed a proposal (received September 17, 2026) to produce multiple drug products at its Durham, NC facility inside Foreign‑Trade Zone 93. The filing lists specific finished products (including therapies for diabetes, migraine, inflammatory conditions, weight management, and early Alzheimer's) and specific foreign‑status components and states these items would be admitted duty free for production. The Board must later authorize the limited FTZ production activity, and public comments are due by November 4, 2026.
Some inputs subject to Section 232/301 rules
The request states certain materials/components may be subject to duties under section 232 of the Trade Expansion Act of 1962 or section 301 of the Trade Act of 1974 depending on country of origin. Those items must be admitted to FTZs in "privileged foreign status" as described in 19 CFR 146.41, per the applicable section 232 and section 301 decisions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20774, Foreign-Trade Zone (FTZ) 16, Notification of Proposed Production Activity; Yazaki North America, Inc.; (Stamped Copper Terminals); Petoskey, Michigan
Yazaki North America wants to start making stamped copper terminals at their Petoskey, Michigan plant using special foreign materials with lower or no import duties. This change could save money on materials like copper and steel alloys, but some parts still face tariffs. People have until November 18, 2026, to share their thoughts before the plan gets the green light.
2026-20776, Foreign-Trade Zone (FTZ) 50, Notification of Proposed Production Activity; Sanyo Denki America, Inc.; (Cooling, Servo, and Power Systems and Assemblies); Torrance, California
Sanyo Denki America in Torrance, California, wants to start making cooling, servo, and power system parts inside Foreign-Trade Zone 50. This means they can use certain imported materials with lower or no import taxes, helping them save money and speed up production. The government is reviewing this plan, which could boost local manufacturing and keep prices competitive.
2026-20775, Foreign-Trade Zone (FTZ) 40, Notification of Proposed Production Activity; Norman Noble Company Inc.; (Implantable Medical Devices); Highland Heights, Ohio
Norman Noble Company in Highland Heights, Ohio, wants to start making implantable medical devices using some imported materials with special trade benefits under Foreign-Trade Zone 40. This move could save money on import duties for parts like tungsten plates and stainless steel tubes. Public comments are open until November 18, 2026, so anyone interested can share their thoughts before the plan moves forward.
2026-20253, Foreign-Trade Zone (FTZ) 75; Authorization of Production Activity; Essai, Inc.; (Semiconductor Test Equipment); Chandler, Arizona
Essai, Inc. in Chandler, Arizona, got the green light to make semiconductor test equipment inside Foreign-Trade Zone 75. This means they can produce their high-tech gear with special trade benefits, helping them save money and speed up operations. The approval was finalized on September 28, 2026, so Essai can start or continue their work without any extra delays.
2026-20254, Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; Qorvo US, Inc.; (Semiconductor Wafers and Modules); Hillsboro, Oregon
Qorvo US, Inc. in Hillsboro, Oregon got the green light to start limited production of semiconductor wafers and modules in Foreign-Trade Zone 45. This means they can use some imported parts with special rules for two years, helping them save money and speed up manufacturing. The approval came after a careful review and public input, so it’s official and ready to roll!
2026-20261, Foreign-Trade Zone (FTZ) 153; Authorization of Limited Production Activity; CMS Circuits, Inc.; (Electronic Manufacturing Services in Aerospace, Industrial, and Medical Applications); Murrieta, California
CMS Circuits, Inc. in Murrieta, California, got the green light to start limited production of electronic parts for aerospace, industrial, and medical uses inside Foreign-Trade Zone 153. This means they can bring in certain fiber optic bundles under special foreign status, but only for two years. The City of San Diego and local businesses will benefit from this move, which could boost local manufacturing and trade.
Previous / Next Documents
Previous: 2026-19697, Certain Dynamic Random Access Memory (DRAM) Devices, Products Containing the Same, and Components Thereof (III); Notice of Institution of Investigation
The U.S. International Trade Commission is launching an investigation into certain DRAM memory devices and related products, following a complaint by Netlist, Inc. They claim these products violate their patents and want to stop their import and sale in the U.S. This could lead to import bans and legal orders soon, affecting companies selling these memory products and possibly shaking up the tech market.
Next: 2026-19699, Foreign-Trade Zone (FTZ) 57, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Concord, North Carolina
Eli Lilly wants to start making several important drug products at their Concord, North Carolina facility under special Foreign-Trade Zone rules. This move helps them save on import duties for certain materials while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The government got their request on September 17, 2026, and is reviewing it to give the green light soon.